
NHS Surgeon First in Europe to Implant TELA Bio’s OviTex LPR Reinforced Tissue Matrix
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the first use of its OviTex LPR Reinforced Tissue Matrix in Europe.
NHS Surgeon First in Europe to Implant TELA Bio’s OviTex LPR Reinforced Tissue Matrix Read More